|
Canada-0-LinensRetail Azienda Directories
|
Azienda News:
- How to Use | PRALUENT® (alirocumab) Injection
Learn about PRALUENT's easy-to-use pre-filled injection pen Follow instructions on how to use PRALUENT or watch a self-injection training video Read Important Safety Information on website
- PRALUENT PRE-FILLED PEN QUICK REFERENCE GUIDE
PRALUENT® (alirocumab) PEN KEY FEATURES click The ready-to-use PRALUENT Pen was designed for self-injection at home The yellow safety needle cover keeps the needle hidden throughout the entire injection A “click” sound tells you that the injection has started
- Instructions For Use PRALUENT Before you start you will need: Injection . . .
Important Information The device is a single-dose disposable pen It contains 75 mg of PRALUENT (alirocumab) in 1 mL The PRALUENT pen contains medicine prescribed by your healthcare provider
- About PRALUENT | PRALUENT® (alirocumab) Injection
See Important Safety Information and Full Prescribing Information Learn more about PRALUENT(R) (alirocumab) Injection
- Starting and Paying for PRALUENT | PRALUENT® (alirocumab) Injection
See Important Safety Information and Full Prescribing Information Learn more about PRALUENT(R) (alirocumab) Injection
- Helpful Resources | PRALUENT® (alirocumab) Injection
Find helpful documents for those considering or already on PRALUENT, and resources to help with the cost of PRALUENT Watch videos about how PRALUENT can help lower cardiovascular risk in adults with CV disease, how to inject PRALUENT, and patients' experiences with PRALUENT Read Important Safety Information on website
- Reduce the Risk of Future CV Events | PRALUENT® (alirocumab) Injection
What is PRALUENT ® (alirocumab)? PRALUENT is an injectable prescription medicine used: to reduce the risk of major adverse cardiovascular (CV) events, such as death from coronary heart disease, heart attack, stroke, or certain types of chest pain conditions (unstable angina) requiring hospitalization, in adults at increased risk for these events
- PRALUENT (alirocumab) Patient Assistance Program (PAP) Re-enrollment Form
PRALUENT (alirocumab) Patient Assistance Program (PAP) Re-enrollment Form PRALUENT® (alirocumab) Patient Assistance Program (PAP) Re-enrollment Form If you need help paying for your medicine, MyPRALUENT may be able to help eligible patients You may qualify for assistance with the cost of your medication if you meet these eligibility requirements
- Guess whos more at risk? - PRALUENT
PRALUENT is administered via an easy-to-use pre-filled pen and is injected under the skin (subcutaneously) every 2 weeks or every 4 weeks (monthly), depending on which dose your doctor prescribes for you
- PRA. 20. 05. 0001 Copay Manual Reimbursement Form. docx - PRALUENT
This form is to be used for reimbursement requests of certain product-specific copay, co-insurance or deductible costs directly and actually incurred for a prescription for PRALUENT® (alirocumab) under the MyPRALUENT Copay Card Program
|
|